Loading
AB
Amarantus Bioscience Holdings, Inc. Stock: price and insider trades · United States
US·Mcap US$63k
Amarantus Bioscience Holdings, Inc.: what insiders have been doing
We have very little insider data for Amarantus Bioscience Holdings, Inc. so far: the most recent filing dates from 2 February 2016. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2012FY ended December 2012 · cache
US$0.00
Analyst consensus
Income statement
Net income-US$21.7M0.0% margin
Valuation
Beta-35.26
Last declaration on 2 February 2016
Declarations1 total
45,283 sharesCommon StockSEC:0001213900-16-010534:0
1 of 1 declaration
About Amarantus Bioscience Holdings, Inc.
Amarantus Bioscience Holdings, Inc. is a biotechnology company focused on developing treatments for neurodegenerative diseases. It is listed on NASDAQ.
